Our company received 50 million yuan in Series B financing.

We obtained the medical device registration certificates(NMPA) for Multiple Real-Time PCR Kit for Detection of 2019-nCoV (fluorescence PCR method) [Certified No. 20203400179], donated and supplied the 2019-nCoV nucleic acid diagnostic kits for our country and abroad.

We obtained the medical device registration certificates(NMPA) for Duplex Real-Time PCR Diagnostic Kit for Rapid Detection of Influenza Viruse A and Influenza Viruse B (PCR fluorescent probe method) [Certified No. 20193400251], Real-Time PCR Kit for Detection of Human Enterovirus (PCR fluorescent probe method) [Certified No. 20193400846] and Multiple Real-Time PCR Kit for Detection of Coxsackievirus A16 and Human Enterovirus 71 (PCR fluorescent probe method) [Certified No. 20193400784].

We were endowed with the “Technology R&D Center of Changping，Beijing”;

Our company passed the ISO 13485 (Medical device-Quality management system-requirements for regulatory);

Three products of our company had successively won the Beijing new product and new technology excellence award which were the food-borne pathogens multiplex PCR testing system (MPS), the 14 food borne pathogens detection kits and Yersinia enterocolitica detection kits ;

We obtained the third category medical device business license and the second category medical device business record certificate;

We were selected as a "Gazelle Enterprise" and listed as the “Patent Application Pilot Center of Beijing”;

We were awarded the” High Tech Enterprise”;

The first PCR multiplex product (five enteropathogenic Escherichia coli detection kits) came out; in the same year, we were endowed with the “High Tech Enterprise of Zhongguancun”;

X-ABT was established;